Cafepharma Today

July 3 2025 - Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
Summit said to be in talks with Astra to license potential rival for Merck’s Keytruda
AstraZeneca board
Intuitive Surgical’s da Vinci 5 robot wins CE mark
Intuitive Surgical board
Novartis drug flunks phase 3 test in giant cell arteritis
Novartis board
Bluebird go-private deal signals the ‘PE-ization of pharma’
General Pharma Discussion board
*please scroll down for all the latest news*

Check open job listings in your area
Click here to get the top four headlines in your inbox Mon-Fri (free)

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Supply chains too often “last cog” implemented in clinical trials
Clinical Trials Arena
Monday, December 9, 2024 - 11:08am
tags:
clinical trials, Asia, supply chain
Merck Reveals Mixed Data From Keytruda/Lynparza Regime In Ovarian Cancer
Yahoo/Benzinga
Monday, December 9, 2024 - 11:06am
tags:
Merck, Keytruda, Lynparza, ovarian cancer, clinical trials
Blue Shield's $500 Million Drug Savings Initiative With Amazon Pharmacy Can Potentially Launch In January
Benzinga
Monday, December 9, 2024 - 11:05am
tags:
Amazon pharmacy, Blue Shield
Enanta's RSV antiviral reduces viral load in phase 2 pediatric study
Fierce Biotech
Monday, December 9, 2024 - 11:03am
tags:
Enanta Pharmaceuticals, RSV, antivirals, clinical trials, pediatric
Novartis reports topline outcomes from Phase IIIB PNH trial of Fabhalta
Clinical Trials Arena
Monday, December 9, 2024 - 10:41am
tags:
Novartis, Fabhalta, PNH, clinical trials
A drug for fewer than 1,000 patients? Awareness and diagnosis are key.
Pharma Voice
Monday, December 9, 2024 - 10:40am
tags:
Zevra Therapeutics, ultra rare diseases, Miplyffa, Niemann-Pick disease
ASH: Merck’s ROR1 drug hits the target in first-line lymphoma
Pharmaphorum
Monday, December 9, 2024 - 10:38am
tags:
ASH 2024, Merck, ROR1, zilo-V, lymphoma
Gene therapy uptake in sickle cell stays slow, despite patient interest
BioPharma Dive
Monday, December 9, 2024 - 10:37am
tags:
gene therapy, sickle cell disease, patients, Casgevy, Lyfgenia, Bluebird Bio, Vertex Pharmaceuticals
Half of pharma and biotech companies using AI and big data
Clinical Trials Arena
Monday, December 9, 2024 - 10:35am
tags:
Big Data, artificial intelligence
Trump, RFK Jr. dine with Pfizer and Lilly execs
Axios
Sunday, December 8, 2024 - 9:55pm
tags:
Donald Trump, Pfizer, Eli Lilly, PhRMA, Robert F Kennedy Jr., cancer
ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia
Fierce Pharma
Sunday, December 8, 2024 - 9:53pm
tags:
ASH 2024, AstraZeneca, Calquence, chronic lymphocytic leukemia, CLL
BioAge shares tumble after decision to halt obesity drug study
BioPharma Dive
Sunday, December 8, 2024 - 9:46pm
tags:
BioAge, obesity, azelaprag, tirzepatide, clinical trials
Novo Nordisk slashes prices of additional insulin products but not until 2026
Fierce Pharma
Sunday, December 8, 2024 - 9:42pm
tags:
Novo Nordisk, insulin, diabetes, drug pricing
US issues order mandating bird flu testing of milk supply
MSN/Reuters
Sunday, December 8, 2024 - 9:39pm
tags:
USDA, bird flu, H5N1
With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close
Fierce Pharma
Sunday, December 8, 2024 - 9:37pm
tags:
Novo Holdings, Catalent, Europe, M&A, CDMOs
FDA outlines accelerated review guidelines in waning days of Biden administration
BioSpace
Friday, December 6, 2024 - 11:23am
tags:
FDA, regulatory, accelerated reviews
Acutus will cut 70% of employees to meet Medtronic obligations
Medtech Dive
Friday, December 6, 2024 - 11:20am
tags:
Acutus Medical, Medtronic, layoffs, Medtech
Teva Announces Agreement to Divest Teva-Takeda, its Business Venture in Japan
Globe Newswire
Friday, December 6, 2024 - 11:03am
tags:
Teva Pharmaceutical, Japan, Teva-Takeda, JKI
AstraZeneca, Daiichi share data behind Dato-DXd do-over amid 2nd bid for lung cancer approval
Fierce Biotech
Friday, December 6, 2024 - 9:51am
tags:
AstraZeneca, Daiichi Sankyo, Dato-DXd
Protara shares spike after cell therapy shows high response rate, no severe side effects in bladder cancer trial
Fierce Biotech
Friday, December 6, 2024 - 9:44am
tags:
Protara Therapeutics, cell therapy, bladder cancer, clinical trials

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Assays Are Always Welcome
In the Pipeline
Down In the Reaction Details
In the Pipeline
The "Healthy Vaccinee" Effect
In the Pipeline
The Continuing Crisis, Part XVI: Get the Hell Out of Your Building
In the Pipeline
Tiny Crystals from Small Extracts
In the Pipeline
Hexanitrogen
In the Pipeline
Stir Bars Can't Be Ignored
In the Pipeline
AI Effects on Drug Patents
In the Pipeline
Mirror Morphine
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.